Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)
Status:
Completed
Trial end date:
2015-05-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the equivalence of the lyophilized formulation of
Takeda's Tetravalent Dengue Vaccine Candidate (TDV) compared with the liquid formulation of
TDV.